Home News NAFDAC urges patent medicine dealers against substandard drugs

NAFDAC urges patent medicine dealers against substandard drugs

by Haruna Gimba
0 comments

By Muhammad Amaan

The National Agency for Food and Drug Administration and Control (NAFDAC) has urged patent medicine dealers not to indulge in selling substandard and counterfeit drugs to Nigerians.

Director-General of the agency, Prof. Mojisola Adeyeye, gave the advice at a one-day sensitisation and awareness campaign against substandard and falsified medical products in Abuja.

Prof. Adeyeye, who was represented by Mr Bitrus Fraden, Director of Post Marketing Surveillance, emphasised that substandard and counterfeit drugs are not only fake, but poisonous and hazardous to human health.

She called on patent medicine dealers to ensure they give out genuine products and qualitative services to the public.

The NAFDAC boss also urged them not to indulge in any dirty act that could implicate them, saying that the laws are there to catch-up with the culprits.

“Do not engage in any sharp practices just because you are driven by money, the welfare of the people should be the driving force. Contribute your quota in sanitising the community against drugs abuse.

“The focus of this meeting is how to avoid substandard and falsified medical products. Source your medical and drugs from the right sources and ensure that your suppliers meet the standard.

“With positive thinking, we will serve Nigerians with products that are better by first scrutinising everything before putting them on our shelves for sale,” Adeyeye said.

In his remarks, Chairman of the Nigeria Association of Patent and Proprietary Medicine Dealers (NAPPMED), Mr Odoh-Theophilus Okwudili appreciated NAFDAC for effective drug regulation and monitoring of pharmaceutical products.

He stated that the agency’s sensitisation programme would ensure safety and quality of medicines, reduce counterfeit medicine in circulation, as well as improved access to genuine products.

Mr Okwudili called on other stakeholders in drug and standard regulations to collaborate with NAFDAC, saying that providing guidance and support for patent medicine dealers should be prioritised.

The event was attended by the representatives of NAPPMED drawn from across the six area councils of the Federal Capital Territory (FCT).

Related Articles

Leave a Comment

About Us

Feature Posts

Newsletter

@2024 – Health Reporters